fluorobenzenes has been researched along with Alloxan Diabetes in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozdemir, S; Ozmen, A; Ozturk, N; Yaras, N | 1 |
| Li, WH; Ma, YX; Xie, Q | 1 |
| An, F; Li, B; Liu, X; Luo, B; Wang, W; Xia, Y; Zhang, C; Zhang, M; Zhang, Y | 1 |
| Guo, C; He, L; Liu, HH; Liu, XD; Pan, GY; Ren, J; Sheng, JJ; Yang, Y; Yao, D; Zhou, WP | 1 |
| Chang, SW; Fang, SY; Hsu, CH; Huang, CC; Lam, CF; Lin, Y; Roan, JN; Tsai, YC | 1 |
| Guo, M; Huang, D; Li, JB; Li, S; Wang, FB; Wei, M; Yan, ML; Yu, T | 1 |
| Cathey, BL; Moukdar, F; Prasad, RY; Wilkinson, L; Wingard, CJ | 1 |
| Allen, TJ; Calkin, AC; Cooper, ME; Forbes, JM; Giunti, S; Jandeleit-Dahm, KA; Thomas, MC | 1 |
| CAI, W; CHEN, LL; CHEN, ZY; FANG, J; LIN, YL; WU, LM | 1 |
| Cotter, M; Forrester, JV; Manivannan, A; Serra, AM; Waddell, J; Xu, H | 1 |
| Chang, SW; Chiou, MH; Fang, SY; Hsu, CH; Huang, CC; Lam, CF; Roan, JN; Tsai, YC | 1 |
| Bramwell, S; Ciruela, A; Dixon, AK; Gonzalez, MI; Lee, K; Pinnock, RD | 1 |
| Cameron, N; Cotter, M; Inkster, M; Nangle, M | 1 |
| Cameron, NE; Cotter, MA; Nangle, MR | 1 |
| Asahara, T; Ii, M; Kusano, KF; Losordo, DW; Nishimura, H; Qin, G; Wecker, A; Yoon, YS | 1 |
| Batejko, O; Feman, SS; Haas, MJ; Hovsepyan, M; Mooradian, AD | 1 |
| Bauersachs, J; Ertl, G; Flierl, U; Fraccarollo, D; Hemberger, M; Schäfer, A; Tas, P; Vogt, C | 1 |
| Albertini, JP; Behar, A; Boulakia, FC; Lestrade, R; Tarhzaoui, K; Valensi, P | 1 |
| Jackson, J; Paulose, CS | 1 |
1 review(s) available for fluorobenzenes and Alloxan Diabetes
| Article | Year |
|---|---|
Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neural Conduction; Pyrimidines; Rats; Regional Blood Flow; Rosuvastatin Calcium; Sciatic Nerve; Sulfonamides; Vasodilation | 2003 |
18 other study(ies) available for fluorobenzenes and Alloxan Diabetes
| Article | Year |
|---|---|
Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart.
Topics: Animals; Calcium; Calcium Channels, L-Type; Diabetes Mellitus, Experimental; Disease Models, Animal; Fluorobenzenes; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Myocytes, Cardiac; Pyrimidines; Rats; Rats, Wistar; rhoA GTP-Binding Protein; Rosuvastatin Calcium; Sarcoplasmic Reticulum; Sulfonamides | 2013 |
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1 | 2013 |
Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Topics: Animals; Blotting, Western; Carrier Proteins; Caspase 1; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fluorobenzenes; Gene Silencing; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammasomes; Interleukin-1beta; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2014 |
Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus.
Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Glucose; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Oleic Acid; Pyrimidines; Rats; Rats, Wistar; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides | 2014 |
Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fluorobenzenes; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Neointima; Oxidative Stress; Pyrimidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Rosuvastatin Calcium; Sulfonamides; Superoxides; Time Factors; Vena Cava, Inferior | 2014 |
Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Fluorobenzenes; Human Umbilical Vein Endothelial Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Infarction; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rosuvastatin Calcium; Sulfonamides; Vascular Endothelial Growth Factor A | 2015 |
Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; Diabetes Mellitus, Experimental; Electric Stimulation; Enzyme Inhibitors; Erectile Dysfunction; Fluorobenzenes; Impotence, Vasculogenic; Intracellular Signaling Peptides and Proteins; Male; Metabolic Syndrome; Nitric Oxide; Obesity; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Zucker; rho-Associated Kinases; Rosuvastatin Calcium; Sulfonamides | 2009 |
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lipid Metabolism; Male; Mice; Mice, Knockout; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Streptozocin; Sulfonamides; Tetrazoles | 2010 |
[Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Postconditioning; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Signal Transduction; Sulfonamides | 2010 |
CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.
Topics: Adoptive Transfer; Animals; Bone Marrow Cells; Capillaries; CD11b Antigen; Cell Adhesion; Cell Communication; Cell Count; Cell Movement; CX3C Chemokine Receptor 1; Diabetes Mellitus, Experimental; Endothelial Cells; Fluorescence; Fluorobenzenes; Leukostasis; Male; Mice; Mice, Inbred C57BL; Microcirculation; Monocytes; Pyrimidines; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Retinal Vessels; Rosuvastatin Calcium; Streptozocin; Sulfonamides | 2012 |
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Topics: Animals; Arteriovenous Shunt, Surgical; Diabetes Mellitus, Experimental; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Rosuvastatin Calcium; Sulfonamides | 2012 |
Identification of MEK1 as a novel target for the treatment of neuropathic pain.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Delivery Systems; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Pain Measurement; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley | 2003 |
Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering.
Topics: Acetylcholine; Animals; Aorta; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electric Stimulation; Erectile Dysfunction; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Penis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation; Vasodilator Agents | 2003 |
Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Fluorobenzenes; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Mutant Strains; Nitric Oxide Synthase Type I; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Rosuvastatin Calcium; Schwann Cells; Sulfonamides; Treatment Outcome; Vasa Nervorum | 2005 |
Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats.
Topics: Animals; Blood-Brain Barrier; Blood-Retinal Barrier; Brain; Capillary Permeability; Coronary Circulation; Dextrans; Diabetes Mellitus, Experimental; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Male; Myocardium; Pyrimidines; Rats; Rats, Inbred F344; Retina; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2005 |
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl CoA Reductases; Male; Nitric Oxide Synthase Type III; Platelet Activation; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Streptozocin; Sulfonamides; Vasoconstriction; Vasodilation | 2007 |
Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.
Topics: Animals; Blood Pressure; Capillaries; Diabetes Mellitus, Experimental; Filtration; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Serum Albumin; Sulfonamides | 2008 |
Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
Topics: Animals; Brain Stem; Cerebral Cortex; Diabetes Mellitus, Experimental; Fluorobenzenes; Kinetics; Male; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Streptozocin; Tritium | 1999 |